naftopidil and Hypertension

naftopidil has been researched along with Hypertension in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Li, X; Liu, J; Wang, C; Wang, J; Wu, Z; Xie, S; Xu, J; Xu, S; Yu, H; Zhang, P; Zhu, Z1
He, C; Li, X; Liu, J; Liu, Y; Ma, F; Wang, C; Wu, H; Xu, J; Yang, X1
Chung, MS; Lee, SH; Yoon, BI1
Imanishi, A; Latifpour, J; Ueda, S; Yamamoto, Y; Yono, M; Yoshida, M1
Furukawa, T; Iwamoto, T; Kawasaki, H; Kushiku, K; Nakamura, S; Ohjimi, H; Takasaki, K1

Trials

1 trial(s) available for naftopidil and Hypertension

ArticleYear
Clinical Efficacy and Safety of Naftopidil Treatment for Patients with Benign Prostatic Hyperplasia and Hypertension: A Prospective, Open-Label Study.
    Yonsei medical journal, 2017, Volume: 58, Issue:4

    Topics: Adrenergic alpha-Antagonists; Aged; Blood Pressure; Demography; Humans; Hypertension; Male; Middle Aged; Naphthalenes; Patient Compliance; Patient Satisfaction; Piperazines; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Surveys and Questionnaires; Treatment Outcome

2017

Other Studies

4 other study(ies) available for naftopidil and Hypertension

ArticleYear
Design, synthesis and biological evaluation of isochroman-4-one hybrids bearing piperazine moiety as antihypertensive agent candidates.
    Bioorganic & medicinal chemistry, 2019, 07-01, Volume: 27, Issue:13

    Topics: Animals; Antihypertensive Agents; Disease Models, Animal; Hypertension; Molecular Structure; Piperazine; Rats

2019
Design, synthesis and biological evaluation of hydrogen sulfide-releasing isochroman-4-one derivatives as new antihypertensive agent candidates.
    Bioorganic & medicinal chemistry, 2022, 06-15, Volume: 64

    Topics: Antihypertensive Agents; Humans; Hydrogen Sulfide; Hypertension; Vasodilation

2022
Differential effects of prazosin and naftopidil on pelvic blood flow and nitric oxide synthase levels in spontaneously hypertensive rats.
    Journal of receptor and signal transduction research, 2008, Volume: 28, Issue:4

    Topics: Adrenergic alpha-Antagonists; Animals; Hypertension; Male; Naphthalenes; Nitric Oxide Synthase; Pelvis; Penis; Piperazines; Prazosin; Prostate; Quinazolines; Quinoxalines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, alpha; Regional Blood Flow; Urinary Bladder

2008
[Antihypertensive effect of naftopidil (KT-611), a novel alpha 1-adrenoceptor antagonist, in freely moving experimental hypertensive rats and dogs].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1990, Volume: 96, Issue:3

    Topics: Administration, Oral; Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Dogs; Heart Rate; Hypertension; Male; Naphthalenes; Piperazines; Rats; Rats, Inbred SHR; Rats, Inbred Strains

1990